Page last updated: 2024-08-26

imipenem, anhydrous and Pneumonia, Bacterial

imipenem, anhydrous has been researched along with Pneumonia, Bacterial in 108 studies

Research

Studies (108)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	18 (16.67)	18.2507
2000's	49 (45.37)	29.6817
2010's	36 (33.33)	24.3611
2020's	5 (4.63)	2.80

Authors

Authors	Studies
Bae, IK; Jeong, SH; Lee, SH; Lee, WG; Lee, YN	1
Docobo-Pérez, F; Domínguez-Herrera, J; García-Curiel, A; Jiménez, L; Jiménez-Mejias, ME; López-Rojas, R; Pachón, J; Pachón-Ibáñez, ME; Pichardo, C	1
Ba, Z; Chang, L; Gou, S; Li, B; Liu, H; Ni, J; Ouyang, X; Zhang, J; Zhang, T; Zhang, Y; Zhong, C; Zhu, N; Zhu, Y	1
Bellanti, F; Copalu, W; Daryani, NM; Gheyas, F; Hilbert, DW; Kulkarni, P; Noormohamed, N; Patel, M; Rizk, ML; Young, K	1
Lodise, TP; O'Donnell, JN	1
Bassetti, M; Bini, L; Giacobbe, DR; Magnè, F; Vena, A	1
Gu, KM; Kim, JY; Kwak, N; Park, J; Yim, JJ; Yoon, SH	1
Bao, C; Chin, W; Ding, B; Fan, W; Gao, S; Hedrick, JL; Hsu, LY; Lee, A; Leong, J; Lou, W; Pu, Q; Tan, JPK; Wu, M; Xu, L; Yang, C; Yang, YY; Zhong, G	1
Chopin, MC; Faure, K; Flateau, C; Guery, B; Harent, S; Vuotto, F; Wallet, F	1
Chen, W; Harris, G; Kanzaki, G; Kuo Lee, R; Lam, CK; Patel, GB; Xu, HH	1
Amemura-Maekawa, J; Ara, T; Kura, F; Morita, M; Nishizuka, M; Sato, C; Seto, J; Suzuki, H; Takeda, H; Tsuchida, F; Watanabe, M	2
Goldberg, D; Pacheco, JM	1
Boutoille, D; Bretonnière, C; Caillon, J; Desessard, C; Guitton, C; Jacqueline, C; Potel, G	1
Balík, M; Lipš, M; Siller, M; Strojil, J; Suchánková, H; Urbánek, K	1
Huang, W; Li, H; Lu, CD; Stratton, CW; Tang, YW; Yan, Y; Yao, X; Zhou, Z	1
Edelstein, PH	1
Ariza-Prota, MA; Budiño, T; Casan, P; Fole-Vázquez, D; García-Clemente, M; Pando-Sandoval, A	1
Akalın, H; Heper, Y; İşçimen, R; Kahveci, F; Kelebek, N; Ocakoğlu, G; Özvatan, T; Sınırtaş, M; Yılmaz, E	1
Gunasekaran, J; Shariff, M	1
Fang, X; Guo, J; Jin, Y; Liu, C; Pan, F; Qin, L; Yan, W	1
Lipš, M; Neely, MN; Strojil, J; Suchánková, H; Urbánek, K	1
Cheong, HJ; Kim, WJ; Lee, J; Song, JY; Sung, AK	1
Cizmeci, Z; Dereli, N; Günay, E; Küçükbayrak, A; Uğurman, F	1
Alves, I; Durocher, A; Grailles, G; Minacori, F; Nseir, S; Soury-Lavergne, A	1
Docobo-Perez, F; Garcia-Curiel, A; Jiménez-Mejías, ME; López-Rojas, R; Pachon, J; Pachón-Ibañez, ME; Pichardo, C	1
Cavallo, JD; Chomarat, M; Dubreuil, L; Joly-Guillou, ML; Kempf, M; Maugein, J; Muller-Serieys, C; Roussel-Delvallez, M	1
Dizbay, M; Hizel, K; Sezer, BE; Tunccan, OG	1
Bauldoff, GS; Mangino, JE; Nunley, DR; Pope-Harman, AL	1
Chuang, YC; Lee, SH; Lin, KH; Yu, WL	1
Gonzalez, F; Li, X; Mu, D; Tang, J; Wang, H; Xiong, Y	1
Chen, J; Mody, SH; Ramsey, AM; Shorr, AF; Zilberberg, MD	1
Deris, ZZ; Hasan, H; Siti Suraiya, MN	1
Boutoille, D; Bretonnière, C; Caillon, J; Guitton, C; Jacqueline, C; Le Mabecque, V; Miégeville, AF; Potel, G; Villers, D	1
Abbanat, D; Barron, A; Bunting, RA; Fernandez, J; Flamm, RK; Hall, L; Hilliard, JJ; Lynch, AS; Melton, JL; Ward, CK	1
Eden, A; Le Falher, G; Le Moing, V; Lesnik, A; Makinson, A; Reynes, J	1
Furtado, GH; Gales, AC; Medeiros, EA; Perdiz, LB; Santos, AE; Wey, SB	1
Docobo-Pérez, F; García-Curiel, A; Ibáñez-Martínez, J; Jiménez-Mejias, ME; Pachón, J; Pachón-Ibáñez, ME; Pichardo, C	1
Akalın, H; Akova, M; Arman, D; Aygen, B; Başaran, S; Bayramoğlu, G; Dizbay, M; Dokuzoğuz, B; Eraksoy, H; Esener, H; Hasçelik, G; Köksal, I; Korten, V; Oğünç, D; Sınırtaş, M; Söyletir, G; Sümerkan, B; Tünger, A; Ulusoy, S; Yalçın, AN	1
Barbeito Castiñeiras, G; Martín Romero Domínguez, M; Martínez-Lamas, L; Palacios Bartolomé, A; Pérez Del Molino Bernal, ML; Rabade Castedo, C	1
Chen, CC; Chen, CH; Chiang, SR; Chuang, YC; Ko, WC; Lee, NY; Shieh, JM; Tang, HJ	1
Boutoille, D; Bretonnière, C; Caillon, J; Desessard, C; Guitton, C; Jacqueline, C; Le Mabecque, V; Miégeville, AF; Potel, G; Villers, D	1
Gu, DQ; Liu, PY; Zhang, KH	1
Choi, SH; Chung, J; Hong, SB; Jang, HJ; Kim, JW; Koh, Y; Lim, CM	1
Chen, P; Cheng, WC; Xiang, XD; Zan, JN	1
Cravarezza, P; Donati, P; Franchino, L; Grassi, V; Pozzi, A; Prometti, P; Ravizzola, G; Romanelli, G; Zulli, R	1
Dhingra, VK; Gorman, SK; Ronco, JJ; Zed, PJ	1
Amiot, DM; Buchman, TG; Coopersmith, CM; Davis, CG; Dunne, WM; Hotchkiss, RS; Husain, KD; Karl, IE; Osborne, DF; Stromberg, PE; Turnbull, IR	1
Boulanger, BR; Fogarty, C; Fowler, C; Kahn, JB; Morgan, N; Oross, M; Tennenberg, A; West, M; Wiesinger, B; Wu, SC	1
Burgmann, H	1
Ayalew, K; Jantausch, BA; Nambiar, S; Yasinskaya, Y	1
Buchheidt, D; Hofheinz, R; Hummel, M	1
Orlov, VA; Shenderovich, VA; Smirnova, LB; Sokolova, VI	1
Brink, AJ; Feldman, C; Grolman, DC; Muckart, D; Pretorius, J; Richards, GA; Senekal, M; Sieling, W	1
Bargon, J; Böddinghaus, B; Frickmann, H; Jungblut, S	1
Bernabéu-Wittel, M; de Cueto, M; del Carmen Conejo, M; García, I; Jiménez-Mejías, ME; Martínez-Martínez, L; Pachón, J; Pachón-Ibáñez, ME; Pascual, A; Pichardo, C	1
Arnal, JM; Berger, P; Franceschini, B; Gainnier, M; Michel, F; Papazian, L; Sainty, JM	1
Kollef, MH; Shorr, AF; Susla, GB	1
Jackson, WL; Kollef, MH; Ramage, AS; Shorr, AF; Tennenberg, AM; Wu, SC; Zadeikis, N	1
Bernabeu-Wittel, M; García-Curiel, A; Ibáñez-Martínez, J; Jiménez-Mejías, ME; Pachón, J; Pachón-Ibáñez, ME; Pichardo, C	1
Aldabó-Pallás, T; Cayuela, A; Fernández-Hinojosa, E; Garcia-Curiel, A; Garnacho-Montero, J; Jiménez-Jiménez, FJ; Marquez-Vácaro, JA; Ortiz-Leyba, C	1
d'Escrivan, T; Devos, P; Dubreuil, L; Georges, H; Kipnis, E; Leroy, O	1
Cokkinos, DD; Giannou, S; Kyriakou, L; Mantzoukis, D; Protopapa, E; Spanou, E	1
Conejo, C; Ibáñez-Martínez, J; Martínez-Martínez, L; Pachón, J; Pachón-Ibañez, ME; Pascual, A; Pichardo, C; Rodríguez-Martínez, JM	1
Craft, D; Lesho, E; Moran, K; Wortmann, G	1
Kuti, JL; Nicolau, DP; Sun, HK	1
Bethimouti, K; Ikonomidis, A; Kondyli, L; Legakis, NJ; Maniatis, AN; Markogiannakis, A; Pournaras, S; Tsakris, A	1
Agodi, A; Anzaldi, A; Barchitta, M; Di Popolo, A; Ghiraldi, E; Mattaliano, A; Travali, S; Zarrilli, R	1
Francis, AL; How, SH; Tee, HP	1
Borchers, M; Teikemeier, F; Theegarten, D; von der Mülbe, B	1
Caillon, J; Christophe Roze, J; Denizot, S; Godon, N; Gras-Le Guen, C; Podevin, G; Potel, G	1
Albertí, S; Alonso, D; Borrell, N; Doménech-Sánchez, A; Gomez, C; Padilla, E; Pérez, JL	1
Couet, W; Dahyot, C; Debaene, B; Marchand, S; Mimoz, O; Pariat, C; Pessini, GL	1
Docobo-Pérez, F; Fernández-Cuenca, F; Pachón, J; Pachón-Ibáñez, ME; Pascual, A	1
Fukuda, Y; Higashiyama, Y; Hirakata, Y; Izumikawa, K; Kohno, S; Miyazaki, Y; Mizuta, Y; Seki, M; Tomono, K; Tsukamoto, K; Yanagihara, K	1
Bahloul, M; Bouaziz, M; Chaari, A; Chelly, H; Dammak, H; Hakim, A; Hamida, CB; Hergafi, L; Kallel, H; Rekik, N	1
Guglielmo, BJ; Yang, K	1
Lakhal, K; Lortat-Jacob, B; Neukirch, C; Pajot, O; Wolff, M	1
Asaoka, N; Honda, Y; Kibayashi, T; Kishimoto, M; Kurihara, T; Nanba, F; Okimoto, N; Osaki, K; Yamato, K	1
Joseph, J; Rodvold, KA	1
Delia, S; Iona, E; Mascellino, MT; Mastroianni, CM; Ponzo, R	1
Matsui, S	1
Wood, CA	1
Bess, DT; Christman, JW; Siami, GA; Wilkins, WT	1
Bastian, A; Bestehorn, K; Büchele, G; Gaus, W; Laubenthal, HJ; Rodloff, AC	1
Cuschieri, P; Galizia, AC; Vassallo, J	1
Carbon, C; Joly-Guillou, ML; Pocidalo, JJ; Walker, F; Wolff, M	1
Chan, CH; Chan, TH; Ho, A; Lai, CK; Leung, R	1
Garau, J; Martínez Lacasa, J	1
Alcaide, F; Carratalà, J; Fernández-Sevilla, A; Gudiol, F; Rosón, B	1
Ashitani, J; Ihi, T; Kohno, S; Matsukura, S; Mukae, H; Sakamoto, A; Taniguchi, H	1
Cornaglia, G; Fontana, R; Lauretti, L; Mazzariol, A; Riccio, ML; Rossolini, GM	1
Caldwell, JW; Johnson, RH; Singh, S	1
Sakai, C; Satoh, Y; Takagi, T	1
Elhelali, N; Jacolot, A; Laurent, F; Léotard, S; Mimoz, O; Nordmann, P; Petitjean, O; Samii, K	1
Xiao, Z	1
Atzeni, R; Bartoloni, A; Buonomini, MI; Corti, G; De Vizzi, GB; Fogliani, V; Franchino, L; Giura, R; Mancini, P; Moretti, AM; Paradisi, F; Petraglia, A; Romanelli, G; Strohmeyer, M	1
Jacolot, A; Leotard, S; Louchahi, K; Mimoz, O; Nordmann, P; Padoin, C; Petitjean, O	1
Caballero, FJ; Cuberos, L; García-Curiel, A; Ibáñez-Martínez, J; Jiménez-Mejías, ME; Moreno, I; Pachón, J; Pichardo, C; Rodríguez-Hernández, MJ	1
Bryskier, A; Carbon, C; Farinotti, R; Joly-Guillou, ML; Wolff, M	1
Alvarez-Lerma, F; Bauer, TT; Blanquer, J; Castillo, F; Leal-Noval, SR; León-Gil, C; Martínez-Pellús, A; Nadal, P; Palomar, M; Ros, F; Torres, A	1
Bingen, E; Bonacorsi, S; Brahimi, N; Gérardin, M; Lebourgeois, M; Mariani-Kurkdjian, P; Munck, A; Navarro, J	1
Higashiyama, Y; Hirakata, Y; Kadota, JI; Kakeya, H; Kaneko, Y; Kohno, S; Kuroki, M; Miyazaki, Y; Ohi, H; Tomono, K; Yanagihara, K	1
Cid, A; Jarque, I; Martín, G; Pérez-Bellés, C; Salavert, M; Sanz, MA	1
Báñez, F; Biechy, M; Gálvez, E; Salgueró, E	1
Badolati, A; Fontán, PA; Gammella, D; Maskin, B; Spinedi, EG	1
Boucher, BA; Croce, MA; Fabian, TC; Hanes, SD; Wood, GC	1

Reviews

9 review(s) available for imipenem, anhydrous and Pneumonia, Bacterial

Article	Year
New Perspectives on Antimicrobial Agents: Imipenem-Relebactam. Antimicrobial agents and chemotherapy, 2022, 07-19, Volume: 66, Issue:7 Topics: Adult; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenems; Humans; Imipenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa	2022
New antibiotics for Gram-negative pneumonia. European respiratory review : an official journal of the European Respiratory Society, 2022, Dec-31, Volume: 31, Issue:166 Topics: Anti-Bacterial Agents; Carbapenems; Cefiderocol; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Pneumonia, Bacterial	2022
Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review. BMC pulmonary medicine, 2010, Aug-26, Volume: 10 Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Imipenem; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Treatment Outcome	2010
Carbapenems in pediatrics. Therapeutic drug monitoring, 2003, Volume: 25, Issue:5 Topics: Child; Humans; Imipenem; Meningitis, Bacterial; Meropenem; Neutropenia; Pneumonia, Bacterial; Thienamycins	2003
Appropriate use of the carbapenems. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2004, Volume: 94, Issue:10 Pt 2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cilastatin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Lactams; Meropenem; Patient Selection; Pneumonia, Bacterial; Practice Patterns, Physicians'; Protease Inhibitors; South Africa; Surgical Wound Infection; Thienamycins; Urinary Tract Infections	2004
Quinolones for treatment of nosocomial pneumonia: a meta-analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Feb-15, Volume: 40 Suppl 2 Topics: Anti-Infective Agents; Cilastatin; Ciprofloxacin; Cross Infection; Humans; Imipenem; Levofloxacin; Meta-Analysis as Topic; Ofloxacin; Pneumonia, Bacterial; Quinolones; Randomized Controlled Trials as Topic	2005
Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms. The Annals of pharmacotherapy, 2007, Volume: 41, Issue:9 Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins	2007
The role of carbapenems in the treatment of severe nosocomial respiratory tract infections. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Doripenem; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Patient Selection; Pneumonia, Bacterial; Respiratory Tract Infections; Severity of Illness Index; Thienamycins; Treatment Outcome	2008
[The role of carbapenems in the treatment of nosocomial infection]. Enfermedades infecciosas y microbiologia clinica, 1997, Volume: 15 Suppl 1 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cross Infection; Drug Therapy, Combination; Humans; Imipenem; Meningitis, Bacterial; Meropenem; Pneumonia, Bacterial; Skin Diseases, Infectious; Thienamycins	1997

Trials

14 trial(s) available for imipenem, anhydrous and Pneumonia, Bacterial

Article	Year
Pharmacokinetics of imipenem in critically ill patients during empirical treatment of nosocomial pneumonia: a comparison of 0.5-h and 3-h infusions. International journal of antimicrobial agents, 2014, Volume: 44, Issue:4 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Critical Illness; Cross Infection; Female; Humans; Imipenem; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Plasma; Pneumonia, Bacterial; Young Adult	2014
Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial. Critical care (London, England), 2012, Feb-15, Volume: 16, Issue:1 Topics: Aged; Anti-Infective Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Female; Hospital Mortality; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Time Factors; Treatment Outcome; Vancomycin	2012
Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy. Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:6 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Community-Acquired Infections; Costs and Cost Analysis; Drug Combinations; Drug Costs; Drug Therapy, Combination; Female; Hospitalization; Humans; Imipenem; Male; Meropenem; Pneumonia, Bacterial; Prospective Studies; Thienamycins; Treatment Outcome	2002
Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study. Clinical therapeutics, 2003, Volume: 25, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Cilastatin; Ciprofloxacin; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Prospective Studies; Pseudomonas aeruginosa	2003
Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Feb-15, Volume: 40 Suppl 2 Topics: Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Cross Infection; Double-Blind Method; Drug Combinations; Drug Resistance, Bacterial; Female; Humans; Imipenem; Levofloxacin; Male; Middle Aged; Multivariate Analysis; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Thienamycins; Treatment Outcome; Ventilators, Mechanical	2005
Clinical comparative study of sulbactam/ampicillin and imipenem/cilastatin in elderly patients with community-acquired pneumonia. Internal medicine (Tokyo, Japan), 2006, Volume: 45, Issue:17 Topics: Age Factors; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Cilastatin; Community-Acquired Infections; Drug Combinations; Female; Humans; Imipenem; Male; Pneumonia, Bacterial; Prospective Studies; Protease Inhibitors; Severity of Illness Index; Sulbactam; Treatment Outcome	2006
Comparison of ciprofloxacin with imipenem in the treatment of severe pneumonia in hospitalised geriatric patients. Drugs, 1995, Volume: 49 Suppl 2 Topics: Aged; Anti-Infective Agents; APACHE; Ciprofloxacin; Double-Blind Method; Hospitalization; Humans; Imipenem; Male; Pneumonia, Bacterial; Prospective Studies; Thienamycins	1995
[Comparative study of the cost-/effectiveness relationship of initial therapy with imipenem/cilastatin in nosocomial pneumonia. Group study]. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 1996, Volume: 31, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cilastatin; Cost-Benefit Analysis; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Protease Inhibitors; Thienamycins; Treatment Outcome	1996
Hospitalized patients with community-acquired pneumonia in Hong Kong: a randomized study comparing imipenem/cilastatin and ceftazidime. Respiration; international review of thoracic diseases, 1997, Volume: 64, Issue:3 Topics: Adult; Aged; Ceftazidime; Cephalosporins; Cilastatin; Community-Acquired Infections; Drug Therapy, Combination; Female; Follow-Up Studies; Hong Kong; Hospitalization; Humans; Imipenem; Injections, Intravenous; Male; Pneumonia, Bacterial; Protease Inhibitors; Survival Rate; Thienamycins	1997
[The clinical manifestation and drug sensitive tests of lower respiratory tract infection by enterobacter cloacae. The Pulmonary Infection and Fibrosis Group, Thoracic Society Shanghai Medical Association]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 1997, Volume: 20, Issue:4 Topics: Adult; Aged; Amikacin; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Humans; Imipenem; Lung Diseases, Obstructive; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Respiratory Tract Infections	1997
Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia. The Journal of antimicrobial chemotherapy, 1999, Volume: 43 Suppl A Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Cost-Benefit Analysis; Cross Infection; Double-Blind Method; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Health Care Costs; Humans; Imipenem; Male; Patient Admission; Pneumonia, Bacterial; Prospective Studies; Retrospective Studies; Thienamycins	1999
Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia. Drugs under experimental and clinical research, 1999, Volume: 25, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cilastatin; Community-Acquired Infections; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Pneumonia, Bacterial; Safety; Thienamycins	1999
Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin. Thorax, 2000, Volume: 55, Issue:12 Topics: Adult; Aged; Anti-Infective Agents; Cilastatin; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Protease Inhibitors; Survival Rate; Thienamycins; Treatment Outcome	2000
Evaluation of endotoxin release and cytokine production induced by antibiotics in patients with Gram-negative nosocomial pneumonia. Critical care medicine, 2002, Volume: 30, Issue:2 Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cross Infection; Cytokines; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-1; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Sepsis; Statistics, Nonparametric; Thienamycins; Tumor Necrosis Factor-alpha	2002

Other Studies

85 other study(ies) available for imipenem, anhydrous and Pneumonia, Bacterial

Article	Year
Novel complex class 1 integron bearing an ISCR1 element in an Escherichia coli isolate carrying the blaCTX-M-14 gene. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8 Topics: Adult; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; DNA Transposable Elements; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Integrons; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Pneumonia, Bacterial; Sequence Analysis, DNA	2007
Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Meningitis, Bacterial; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rabbits; Rifampin; Sulbactam; Treatment Outcome	2010
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice. Journal of medicinal chemistry, 2021, 08-12, Volume: 64, Issue:15 Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Pneumonia, Bacterial; Pore Forming Cytotoxic Proteins; Structure-Activity Relationship; Wasp Venoms	2021
Population pharmacokinetic/pharmacodynamic assessment of imipenem/cilastatin/relebactam in patients with hospital-acquired/ventilator-associated bacterial pneumonia. Clinical and translational science, 2022, Volume: 15, Issue:2 Topics: Adult; Anti-Bacterial Agents; Azabicyclo Compounds; Cilastatin; Hospitals; Humans; Imipenem; Pneumonia, Bacterial; Ventilators, Mechanical	2022
Radiographic severity and treatment outcome of Mycobacterium abscessus complex pulmonary disease. Respiratory medicine, 2021, Volume: 187 Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefoxitin; Drug Therapy, Combination; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Pneumonia, Bacterial; Radiography, Thoracic; Retrospective Studies; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome	2021
Degradable antimicrobial polycarbonates with unexpected activity and selectivity for treating multidrug-resistant Klebsiella pneumoniae lung infection in mice. Acta biomaterialia, 2019, Volume: 94 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biocompatible Materials; Cell Line; Cell Membrane; Cytosol; Drug Resistance, Multiple, Bacterial; Epithelial Cells; Female; Guanidine; Humans; Imipenem; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lung Diseases; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumonia, Bacterial; Polycarboxylate Cement; Polymers; Protein Binding	2019
[Nocardia pseudobrasiliensis pneumonia in a heart transplant recipient]. Medecine et maladies infectieuses, 2013, Volume: 43, Issue:2 Topics: Acetamides; Adult; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Heart Transplantation; Humans; Imipenem; Immunocompromised Host; Linezolid; Male; Nocardia; Nocardia Infections; Oxazolidinones; Pneumonia, Bacterial; Postoperative Complications; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination	2013
A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:8 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacteremia; Bacterial Vaccines; Body Weight; Bronchopneumonia; Disease Models, Animal; Female; Imipenem; Immunization; Lung; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Reproducibility of Results; Tigecycline; Time Factors	2013
A case of pneumonia caused by Legionella pneumophila serogroup 12 and treated successfully with imipenem. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014, Volume: 20, Issue:6 Topics: Aged, 80 and over; Anti-Bacterial Agents; Humans; Imipenem; Japan; Legionella pneumophila; Legionnaires' Disease; Male; Pneumonia, Bacterial; Serotyping; Sputum	2014
A curious cause of cavitations: Nocardia pneumonia. The American journal of medicine, 2014, Volume: 127, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Amikacin; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Bronchoscopy; Clindamycin; Comorbidity; Fever; Hemoptysis; Humans; Imipenem; Immunocompromised Host; Lung Abscess; Male; Middle Aged; Neuroimaging; Nocardia Infections; Pneumonia, Bacterial; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination; Weight Loss	2014
In vivo efficacy of ceftolozane against Pseudomonas aeruginosa in a rabbit experimental model of pneumonia: comparison with ceftazidime, piperacillin/tazobactam and imipenem. International journal of antimicrobial agents, 2014, Volume: 44, Issue:3 Topics: Animal Structures; Animals; Anti-Bacterial Agents; Bacterial Load; Ceftazidime; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Female; Humans; Imipenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Treatment Outcome	2014
A novel Pseudomonas aeruginosa strain with an oprD mutation in relation to a nosocomial respiratory infection outbreak in an intensive care unit. Journal of clinical microbiology, 2014, Volume: 52, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Disease Outbreaks; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Frameshift Mutation; Genetic Complementation Test; Genotype; Humans; Imipenem; Intensive Care Units; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Typing; Mutagenesis, Insertional; Pneumonia, Bacterial; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA; Sputum	2014
Imipenem therapy for Legionnaires' disease. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:1 Topics: Anti-Bacterial Agents; Humans; Imipenem; Legionella pneumophila; Legionnaires' Disease; Male; Pneumonia, Bacterial	2015
Reply to the letter to the editor by Edelstein PH. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:1 Topics: Anti-Bacterial Agents; Humans; Imipenem; Legionella pneumophila; Legionnaires' Disease; Male; Pneumonia, Bacterial	2015
Community-acquired bacteremic Streptomyces atratus pneumonia in animmunocompetent adult: a case report. Journal of medical case reports, 2015, Nov-20, Volume: 9 Topics: Actinomycetales Infections; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Community-Acquired Infections; Humans; Imipenem; Immunocompetence; Levofloxacin; Male; Pneumonia, Bacterial; Sequence Analysis, DNA; Streptomyces; Treatment Outcome	2015
Nosocomial Acinetobacter pneumonia: Treatment and prognostic factors in 356 cases. Respirology (Carlton, Vic.), 2016, Volume: 21, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Prognosis; Retrospective Studies; Risk Factors; Severity of Illness Index; Shock, Septic	2016
Pulmonary Nocardiosis: Review of Cases and an Update. Canadian respiratory journal, 2016, Volume: 2016 Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Cough; Diabetes Mellitus; Dyspnea; Female; Humans; Imipenem; Immunocompromised Host; India; Male; Meropenem; Middle Aged; Nocardia Infections; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary	2016
Hospital-acquired pneumonia due to Achromobacter xylosoxidans in the elderly: A single-center retrospective study in Beijing. Journal of infection in developing countries, 2017, Jan-30, Volume: 11, Issue:1 Topics: Achromobacter denitrificans; Aged; Aged, 80 and over; Anti-Bacterial Agents; Beijing; beta-Lactam Resistance; Catheters, Indwelling; Cross Infection; Female; Gram-Negative Bacterial Infections; Hospitals, General; Hospitals, Veterans; Humans; Imipenem; Male; Pneumonia, Bacterial; Retrospective Studies; Risk Factors	2017
Is continuous infusion of imipenem always the best choice? International journal of antimicrobial agents, 2017, Volume: 49, Issue:3 Topics: Aged; Anti-Bacterial Agents; Critical Illness; Cross Infection; Female; Gram-Negative Bacteria; Humans; Imipenem; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Plasma; Pneumonia, Bacterial; Staphylococcus aureus; Time Factors	2017
Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model. International journal of antimicrobial agents, 2009, Volume: 33, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Immunosuppression Therapy; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Pneumonia, Bacterial; Rifampin; Treatment Outcome	2009
[A community acquired pneumonia case caused by Ralstonia pickettii]. Mikrobiyoloji bulteni, 2009, Volume: 43, Issue:2 Topics: Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Community-Acquired Infections; Drug Combinations; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Middle Aged; Opportunistic Infections; Pneumonia, Bacterial; Protease Inhibitors; Pulmonary Disease, Chronic Obstructive; Ralstonia pickettii; Treatment Outcome	2009
Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:7 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Causality; Ceftazidime; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Infection Control; Intensive Care Units; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Patient Admission; Pneumonia, Bacterial; Practice Guidelines as Topic; Prospective Studies; Pseudomonas aeruginosa; Risk Factors; Societies, Medical; Stenotrophomonas maltophilia	2010
Efficacy of tigecycline vs. imipenem in the treatment of experimental Acinetobacter baumannii murine pneumonia. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Area Under Curve; Disease Models, Animal; Female; Imipenem; Lung; Mice; Mice, Inbred C57BL; Minocycline; Pneumonia, Bacterial; Statistics, Nonparametric; Tigecycline	2010
Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study. BMC infectious diseases, 2010, Mar-18, Volume: 10 Topics: Anti-Bacterial Agents; Bacteremia; France; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Thienamycins; Wound Infection	2010
Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors. Scandinavian journal of infectious diseases, 2010, Volume: 42, Issue:10 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Incidence; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Respiration, Artificial; Risk Factors	2010
Mortality associated with Acinetobacter baumannii infections experienced by lung transplant recipients. Lung, 2010, Volume: 188, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Humans; Imipenem; Immunosuppressive Agents; Lung Transplantation; Minocycline; Pneumonia, Bacterial; Radiography; Retrospective Studies; Tigecycline	2010
In vitro synergistic antimicrobial effect of imipenem and colistin against an isolate of multidrug-resistant Enterobacter cloacae. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2010, Volume: 43, Issue:4 Topics: Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Enterobacter cloacae; Female; Gram-Positive Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Microbial Viability; Middle Aged; Pneumonia, Bacterial; Sputum; Time Factors	2010
Neonatal community-acquired pneumonia: pathogens and treatment. Journal of paediatrics and child health, 2010, Volume: 46, Issue:11 Topics: Anti-Bacterial Agents; China; Community-Acquired Infections; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infant, Newborn; Male; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Retrospective Studies; Sputum; Thienamycins; Vancomycin	2010
Clinical characteristics and outcomes of bacteraemic melioidosis in a teaching hospital in a northeastern state of Malaysia: a five-year review. Journal of infection in developing countries, 2010, Aug-04, Volume: 4, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Burkholderia pseudomallei; Ceftazidime; Female; Hospitals, Teaching; Humans; Imipenem; Liver Abscess; Malaysia; Male; Melioidosis; Middle Aged; Pneumonia, Bacterial; Testicular Hydrocele; Treatment Outcome; Young Adult	2010
Efficacy of doripenem in the treatment of Pseudomonas aeruginosa experimental pneumonia versus imipenem and meropenem. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:11 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Blood; Carbapenems; Disease Models, Animal; Doripenem; Female; Imipenem; Infusions, Intravenous; Lung; Meropenem; Plasma; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Spleen; Thienamycins; Treatment Outcome	2010
Comparative effects of carbapenems on bacterial load and host immune response in a Klebsiella pneumoniae murine pneumonia model. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; Carbapenems; Cytokines; Disease Models, Animal; Doripenem; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lung; Meropenem; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins; Treatment Outcome	2011
[Two cases of pulmonary gangrene in HIV-infected patients: favorable outcome without surgery]. Medecine et maladies infectieuses, 2011, Volume: 41, Issue:2 Topics: Acetamides; Adult; Alcoholism; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Gangrene; Gentamicins; HIV Infections; Humans; Imipenem; Linezolid; Lung; Male; Metronidazole; Necrosis; Ofloxacin; Oxazolidinones; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Smoking; Tomography, X-Ray Computed	2011
Risk factors for hospital-acquired pneumonia caused by imipenem-resistant Pseudomonas aeruginosa in an intensive care unit. Anaesthesia and intensive care, 2010, Volume: 38, Issue:6 Topics: Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors	2010
Efficacy of rifampin, in monotherapy and in combinations, in an experimental murine pneumonia model caused by panresistant Acinetobacter baumannii strains. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2011, Volume: 30, Issue:7 Topics: Acinetobacter baumannii; Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Imipenem; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microbial Viability; Pneumonia, Bacterial; Rifampin; Rodent Diseases; Sulbactam; Treatment Outcome	2011
[Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study]. Mikrobiyoloji bulteni, 2011, Volume: 45, Issue:2 Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins; Turkey	2011
[Pandoraea sputorum colonization in a patient with cystic fibrosis]. Archivos de bronconeumologia, 2011, Volume: 47, Issue:11 Topics: Anti-Bacterial Agents; Bronchiectasis; Burkholderia cepacia complex; Burkholderia Infections; Child; Cystic Fibrosis; Cytokines; Drug Resistance, Multiple, Bacterial; Female; Follow-Up Studies; Humans; Imipenem; Pneumonia, Bacterial; Pseudomonas Infections; Sputum; Superinfection; Virulence	2011
Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2012, Volume: 16, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Disease; Animals; Anti-Bacterial Agents; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Colistin; Cytokines; Disease Models, Animal; Drug Combinations; Drug Resistance, Bacterial; Female; Imipenem; Meropenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pneumonia, Bacterial; Stem Cells; Thienamycins	2012
Evaluation of doripenem in an experimental model of resistant Pseudomonas aeruginosa pneumonia. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:3 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactam Resistance; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Doripenem; Humans; Imipenem; Lung; Meropenem; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Thienamycins; Treatment Outcome	2012
[Lower respiratory tract of pneumoconiosis on fosfomycin antibacterial activity in vitro of fosfomycin to infected in coal worker pneumoconiosis in vitro antibacterial activity]. Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases, 2011, Volume: 29, Issue:7 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anthracosis; Anti-Bacterial Agents; Drug Resistance, Bacterial; Fosfomycin; Humans; Imipenem; Pneumonia, Bacterial	2011
[Distribution of bacteria and analysis of their sensibility to antibiotics in patients with hospital-acquired pneumonia]. Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University, 2000, Dec-28, Volume: 25, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Cefoperazone; Ceftriaxone; Cross Infection; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus epidermidis	2000
Rapid imipenem/cilastatin desensitization for multidrug-resistant Acinetobacter pneumonia. The Annals of pharmacotherapy, 2003, Volume: 37, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Hypersensitivity; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Male; Pneumonia, Bacterial; Protease Inhibitors	2003
Antibiotics improve survival and alter the inflammatory profile in a murine model of sepsis from Pseudomonas aeruginosa pneumonia. Shock (Augusta, Ga.), 2003, Volume: 19, Issue:5 Topics: Animals; Anti-Bacterial Agents; Biomarkers; Cytokines; Disease Models, Animal; Gentamicins; Imipenem; Interleukin-6; Lipopolysaccharides; Mice; Mice, Inbred Strains; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Survival Analysis; Time Factors	2003
Determination of the frequency of inadequate antibiotic therapy using calculation of indication failure (IF), cumulative indication failure (CIF), and balanced indication failure (BIF). Wiener medizinische Wochenschrift (1946), 2003, Volume: 153, Issue:7-8 Topics: Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Multiple; Empiricism; Enterobacteriaceae Infections; Humans; Imipenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Treatment Failure	2003
Severe Chlamydia pneumoniae infection in a patient with mild neutropenia during treatment of Hodgkin's disease. Annals of hematology, 2004, Volume: 83, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aza Compounds; Bleomycin; Chlamydophila Infections; Chlamydophila pneumoniae; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Fluoroquinolones; Hodgkin Disease; Humans; Imipenem; Immunocompromised Host; Moxifloxacin; Neutropenia; Pneumonia, Bacterial; Quinolines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Vincristine	2004
[Clinical efficacy of carbapenems in the treatment of destructive pneumonia and chronic purulent bronchitis]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2003, Volume: 48, Issue:10 Topics: Adult; Aged; Anti-Bacterial Agents; Bronchitis, Chronic; Carbapenems; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Imipenem; Injections, Intramuscular; Injections, Intravenous; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Thienamycins	2003
[Pneumonia induced by nocardia -- a case report]. Pneumologie (Stuttgart, Germany), 2004, Volume: 58, Issue:12 Topics: Amikacin; Drug Therapy, Combination; Humans; Imipenem; Male; Middle Aged; Nocardia; Nocardia Infections; Pneumonia, Bacterial; Polymerase Chain Reaction; Treatment Outcome	2004
Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:1 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Colony Count, Microbial; Guinea Pigs; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lung; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Porins; Thienamycins; Treatment Outcome	2005
Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures. Chest, 2005, Volume: 127, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteriological Techniques; Bronchoalveolar Lavage Fluid; Cephalosporins; Cross Infection; Early Diagnosis; Female; France; Humans; Imipenem; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Population Surveillance; Practice Guidelines as Topic; Prospective Studies; Pseudomonas Infections; Treatment Outcome; Ventilators, Mechanical	2005
Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Guinea Pigs; Imipenem; Lung; Microbial Sensitivity Tests; Pneumonia, Bacterial	2005
Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive care medicine, 2005, Volume: 31, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Male; Middle Aged; Multivariate Analysis; Pneumonia, Bacterial; Prognosis; Prospective Studies; Regression Analysis; Respiration, Artificial; Retrospective Studies; Risk Factors; Spain	2005
Hospital-acquired pneumonia in critically ill patients: factors associated with episodes due to imipenem-resistant organisms. Infection, 2005, Volume: 33, Issue:3 Topics: Acinetobacter baumannii; Aged; Anti-Bacterial Agents; Critical Illness; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa; Risk Factors; Staphylococcus aureus; Stenotrophomonas maltophilia	2005
Pulmonary nocardiosis in a patient with idiopathic thrombocytopenic purpura. The Journal of infection, 2006, Volume: 52, Issue:2 Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Diabetes Complications; Drug Combinations; Drug Therapy, Combination; Fatal Outcome; Humans; Imipenem; Immune Tolerance; Male; Middle Aged; Nocardia asteroides; Nocardia Infections; Pneumonia, Bacterial; Purpura, Thrombocytopenic; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination	2006
Efficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 beta-Lactamase. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:8 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Disease Models, Animal; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Porins; Treatment Outcome	2005
Fatal Acinetobacter baumannii infection with discordant carbapenem susceptibility. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Sep-01, Volume: 41, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Fatal Outcome; Humans; Imipenem; Male; Meropenem; Pneumonia, Bacterial; Thienamycins	2005
Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program. Critical care medicine, 2005, Volume: 33, Issue:10 Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross Infection; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Thienamycins	2005
Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit. The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Intensive Care Units; Pneumonia, Bacterial; Urinary Tract Infections	2006
Alert surveillance of intensive care unit-acquired Acinetobacter infections in a Sicilian hospital. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2006, Volume: 12, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Gene Transfer, Horizontal; Humans; Imipenem; Integrons; Intensive Care Units; Italy; Meropenem; Morbidity; Pneumonia, Bacterial; Thienamycins	2006
Chromobacterium violaceum infection. British journal of hospital medicine (London, England : 2005), 2006, Volume: 67, Issue:4 Topics: Adult; Anti-Bacterial Agents; Chromobacterium; Fatal Outcome; Gram-Negative Bacterial Infections; Humans; Imipenem; Liver Abscess, Pyogenic; Male; Pneumonia, Bacterial; Skin Diseases, Bacterial	2006
[Pulmonary nocardiasis with abscesses spreading to cerebrum, cerebellum and orbits]. Deutsche medizinische Wochenschrift (1946), 2006, May-12, Volume: 131, Issue:19 Topics: Aged; Amikacin; Anti-Bacterial Agents; Biopsy, Needle; Brain Abscess; Cerebellar Diseases; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Imipenem; Lung Abscess; Magnetic Resonance Imaging; Nocardia Infections; Orbital Diseases; Pneumonia, Bacterial; Tomography, X-Ray Computed; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination	2006
Effectiveness of linezolid and imipenem association in the treatment of severe community-acquired pneumonia in children: two case reports. Scandinavian journal of infectious diseases, 2006, Volume: 38, Issue:5 Topics: Acetamides; Anti-Bacterial Agents; Child, Preschool; Community-Acquired Infections; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipenem; Linezolid; Male; Oxazolidinones; Pneumonia, Bacterial; Safety; Treatment Outcome	2006
Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6 Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Colony Count, Microbial; Imipenem; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Plasmids; Pneumonia, Bacterial; Porins; Rats; Rats, Wistar; Thienamycins; Treatment Outcome	2006
Microdialysis study of imipenem distribution in skeletal muscle and lung extracellular fluids of Acinetobacter baumannii-infected rats. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Extracellular Fluid; Imipenem; Lung; Male; Microdialysis; Muscle, Skeletal; Pneumonia, Bacterial; Rats; Rats, Sprague-Dawley	2006
Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam. The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Imipenem; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mutation; Pneumonia, Bacterial; Rifampin; Sulbactam	2006
Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study. Intensive care medicine, 2007, Volume: 33, Issue:7 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Case-Control Studies; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Injections, Intravenous; Intensive Care Units; Male; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas Infections; Retrospective Studies; Time Factors	2007
Safe use of meropenem in a patient with a possible nonimmediate allergy to imipenem. Pharmacotherapy, 2007, Volume: 27, Issue:9 Topics: Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Reactions; Drug Combinations; Drug Hypersensitivity; Female; Humans; Hypersensitivity, Delayed; Imipenem; Meropenem; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	2007
[Study of the cases with multidrug-resistant Pseudomonas aeruginosa by sputum culture]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2007, Volume: 45, Issue:10 Topics: Adult; Aged; Amikacin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Imipenem; Japan; Klebsiella pneumoniae; Male; Methicillin Resistance; Middle Aged; Pneumonia, Bacterial; Prognosis; Pseudomonas aeruginosa; Retrospective Studies; Sputum; Staphylococcus aureus; Time Factors	2007
Infections due to Rhodococcus equi in three HIV-infected patients: microbiological findings and antibiotic susceptibility. International journal of clinical pharmacology research, 1994, Volume: 14, Issue:5-6 Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Bacteremia; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; HIV Infections; Humans; Imipenem; Male; Pleurisy; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Sputum; Teicoplanin; Vancomycin	1994
[A case of severe pneumonia in an elderly man, caused by Citrobacter freundii suspected to have a low susceptibility to imipenem/cilastatin sodium]. Nihon Kyobu Shikkan Gakkai zasshi, 1994, Volume: 32, Issue:11 Topics: Aged; Aged, 80 and over; Cilastatin; Cilastatin, Imipenem Drug Combination; Citrobacter freundii; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae Infections; Gentamicins; Humans; Imipenem; Male; Pneumonia, Bacterial	1994
Treatment of severe pneumonia with ciprofloxacin or imipenem. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:8 Topics: Ciprofloxacin; Humans; Imipenem; Pneumonia, Bacterial	1994
Mixed pulmonary infection with Nocardia, Candida, methicillin-resistant Staphylococcus aureus, and group D Streptococcus species. Postgraduate medical journal, 1996, Volume: 72, Issue:853 Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Clotrimazole; Drug Therapy, Combination; Fluconazole; Fusidic Acid; Humans; Imipenem; Immunocompromised Host; Male; Methicillin Resistance; Nocardia Infections; Pneumonia; Pneumonia, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Vancomycin	1996
Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:2 Topics: Acinetobacter; Acinetobacter Infections; Animals; Colony Count, Microbial; Female; Imipenem; Lung; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neutrophils; Pneumonia, Bacterial; Species Specificity; Thienamycins; Treatment Outcome; Virulence	1997
Bacteremic pneumonia in neutropenic patients with cancer: causes, empirical antibiotic therapy, and outcome. Archives of internal medicine, 1998, Apr-27, Volume: 158, Issue:8 Topics: Aged; Bacteremia; Ceftazidime; Cephalosporins; Female; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Pneumonia, Bacterial; Thienamycins; Treatment Outcome	1998
Pulmonary Nocardia otitidiscaviarum infection in a patient with chronic respiratory infection. Internal medicine (Tokyo, Japan), 1998, Volume: 37, Issue:10 Topics: Aged; Agricultural Workers' Diseases; Bronchoalveolar Lavage Fluid; Chronic Disease; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imipenem; Male; Microbial Sensitivity Tests; Minocycline; Nocardia; Nocardia Infections; Opportunistic Infections; Pneumonia, Bacterial; Species Specificity; Trimethoprim, Sulfamethoxazole Drug Combination	1998
Appearance of IMP-1 metallo-beta-lactamase in Europe. Lancet (London, England), 1999, Mar-13, Volume: 353, Issue:9156 Topics: Acinetobacter; Alleles; Bacterial Proteins; beta-Lactamases; Drug Resistance, Multiple; Europe; Fatal Outcome; Humans; Imipenem; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins	1999
Nocardia asteroides pneumonia, subcutaneous abscess and meningitis in a patient with advanced malignant lymphoma: successful treatment based on in vitro antimicrobial susceptibility. Internal medicine (Tokyo, Japan), 1999, Volume: 38, Issue:8 Topics: Abscess; Drug Therapy, Combination; Erythromycin; Fatal Outcome; Humans; Imipenem; In Vitro Techniques; Lymphoma, B-Cell; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Middle Aged; Nocardia asteroides; Nocardia Infections; Pneumonia, Bacterial; Steroids	1999
Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:1 Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Imipenem; Lung; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar	1999
[Clinical of 50 cases of aged patients with pneumonia caused by gram-negative bacteria]. Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University, 1998, Volume: 23, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Therapy, Combination; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Kanamycin; Male; Middle Aged; Penicillins; Pneumonia, Bacterial; Thienamycins	1998
Efficacies of imipenem, meropenem, cefepime, and ceftazidime in rats with experimental pneumonia due to a carbapenem-hydrolyzing beta-lactamase-producing strain of Enterobacter cloacae. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:4 Topics: Animals; Anti-Bacterial Agents; Area Under Curve; beta-Lactamases; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Creatinine; Drug Resistance, Microbial; Enterobacter cloacae; Enterobacteriaceae Infections; Half-Life; Imipenem; Kidney Diseases; Male; Meropenem; Penicillinase; Pneumonia, Bacterial; Protein Binding; Rats; Rats, Wistar; Thienamycins; Uranyl Nitrate	2000
Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia. The Journal of antimicrobial chemotherapy, 2000, Volume: 45, Issue:4 Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Doxycycline; Drug Therapy, Combination; Female; Imipenem; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Survival Analysis; Thienamycins; Time Factors	2000
In vivo activity of levofloxacin alone or in combination with imipenem or amikacin in a mouse model of Acinetobacter baumannii pneumonia. The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:5 Topics: Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Disease Models, Animal; Drug Therapy, Combination; Female; Imipenem; Levofloxacin; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Bacterial; Thienamycins	2000
Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization. Pediatric pulmonology, 2001, Volume: 32, Issue:4 Topics: Administration, Inhalation; Administration, Oral; Ceftazidime; Child; Child, Preschool; Chronic Disease; Colistin; Colony Count, Microbial; Cystic Fibrosis; DNA, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Imipenem; Infant; Male; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Assessment; Tobramycin	2001
Effects of parenterally administered ciprofloxacin in a murine model of pulmonary Pseudomonas aeruginosa infection mimicking ventilator-associated pneumonia. Chemotherapy, 2001, Volume: 47, Issue:6 Topics: Animals; Anti-Infective Agents; Area Under Curve; Cefozopran; Cephalosporins; Cilastatin; Ciprofloxacin; Disease Models, Animal; Imipenem; Infusions, Parenteral; Male; Mice; Pneumonia, Bacterial; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Respiration, Artificial; Thienamycins	2001
Recurrent bacteremia caused by Rhodococcus equi in a non-neutropenic patient with acute myeloid leukemia in complete remission. Haematologica, 2002, Volume: 87, Issue:1 Topics: Actinomycetales Infections; Adult; Amikacin; Bacteremia; Catheters, Indwelling; Ceftazidime; Cilastatin; Drug Resistance; Drug Therapy, Combination; Erythromycin; Female; Humans; Imipenem; Immunocompromised Host; Leukemia, Myelomonocytic, Acute; Neutropenia; Pneumonia, Bacterial; Recurrence; Rhodococcus equi; Vancomycin	2002
[Soft-tissue abscess caused by Rhodococcus equi in a patient on hemodialysis]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2001, Volume: 21, Issue:6 Topics: Abscess; Actinomycetales Infections; Adrenal Cortex Hormones; Aged; Amikacin; Anti-Glomerular Basement Membrane Disease; Ciprofloxacin; Clarithromycin; Cyclophosphamide; Disease Susceptibility; Drug Therapy, Combination; Female; Humans; Imipenem; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Opportunistic Infections; Pneumonia, Bacterial; Renal Dialysis; Rhodococcus equi; Thigh	2001
Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Jun-01, Volume: 34, Issue:11 Topics: Acinetobacter; Adult; Ampicillin; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Treatment Outcome; Ventilators, Mechanical	2002